Simplex Trading
SGMO

Simplex Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Simplex Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,609
Closed -$5.09K – 9909
2025
Q3 		$6K Sell
9,609
-115,724
-92% -$62.4K ﹤0.01% 8227
2025
Q2 		$67K Sell
125,333
-116,961
-48% -$69.5K ﹤0.01% 5629
2025
Q1 		$158K Buy
242,294
+49,756
+26% +$52.7K ﹤0.01% 4575
2024
Q4 		$196K Buy
192,538
+77,802
+68% +$142K ﹤0.01% 4540
2024
Q3 		$99K Buy
114,736
+70,832
+161% +$51.9K ﹤0.01% 5245
2024
Q2 		$15K Buy
43,904
+989
+2% +$534 ﹤0.01% 7144
2024
Q1 		$28K Buy
42,915
+11,934
+39% +$8.66K ﹤0.01% 6816
2023
Q4 		$16K Sell
30,981
-8,504
-22% -$3.92K ﹤0.01% 7103
2023
Q3 		$23K Sell
39,485
-11,945
-23% -$12.8K ﹤0.01% 6513
2023
Q2 		$66K Buy
51,430
+24,128
+88% +$33K ﹤0.01% 5548
2023
Q1 		$48K Buy
27,302
+16,731
+158% +$47.7K ﹤0.01% 5972
2022
Q4 		$33K Sell
10,571
-17,211
-62% -$66.8K ﹤0.01% 6347
2022
Q3 		$136K Buy
27,782
+15,788
+132% +$81.1K ﹤0.01% 5100
2022
Q2 		$49K Sell
11,994
-30,546
-72% -$132K ﹤0.01% 6519
2022
Q1 		$247K Sell
42,540
-10,012
-19% -$59.5K ﹤0.01% 4836
2021
Q4 		$394K Buy
52,552
+29,258
+126% +$254K ﹤0.01% 4147
2021
Q3 		$279K Buy
23,294
+300
+1% +$2.97K ﹤0.01% 5039
2021
Q2 		$275K Buy
22,994
+8,248
+56% +$93.4K ﹤0.01% 5139
2021
Q1 		$0 Sell
14,746
-46,066
-76% -$621K ﹤0.01% 9898
2020
Q4 		$948K Buy
60,812
+31,640
+108% +$371K ﹤0.01% 2630
2020
Q3 		$275K Sell
29,172
-35,068
-55% -$379K ﹤0.01% 3705
2020
Q2 		$575K Buy
64,240
+40,558
+171% +$376K ﹤0.01% 2743
2020
Q1 		$150K Sell
23,682
-31,045
-57% -$230K ﹤0.01% 3922
2019
Q4 		$458K Buy
54,727
+3,438
+7% +$31.6K ﹤0.01% 2835
2019
Q3 		$464K Buy
51,289
+630
+1% +$7.07K ﹤0.01% 2696
2019
Q2 		$545K Buy
50,659
+41,209
+436% +$438K ﹤0.01% 2480
2019
Q1 		$90K Sell
9,450
-30,730
-76% -$314K ﹤0.01% 4458
2018
Q4 		$461K Buy
40,180
+23,220
+137% +$288K ﹤0.01% 2311
2018
Q3 		$287K Sell
16,960
-33,783
-67% -$513K ﹤0.01% 3233
2018
Q2 		$720K Buy
50,743
+343
+0.7% +$5.7K ﹤0.01% 2102
2018
Q1 		$957K Buy
+50,400
New +$1.08M 0.04% 409
2017
Q2 		– Sell
-1,605
Closed -$10.3K – 6717
2017
Q1 		$8K Buy
+1,605
New +$6.44K ﹤0.01% 4195
2016
Q1 		– Sell
-12,368
Closed -$74.3K – 6162
2015
Q4 		$112K Buy
12,368
+3,744
+43% +$28.9K 0.01% 1268
2015
Q3 		$48K Buy
+8,624
New +$71.1K ﹤0.01% 2034
2015
Q2 		– Sell
-26,946
Closed -$347K – 5786
2015
Q1 		$422K Buy
26,946
+22,677
+531% +$351K 0.05% 380
2014
Q4 		$65K Buy
+4,269
New +$51.8K 0.01% 1185

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Simplex Trading's SGMO Position: Q4 2025 in Review

Simplex Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 9,609 shares — an estimated $5.09K sold.

Simplex Trading first reported a position in SGMO in Q4 2014 and held it in 36 quarters. The position peaked at $957K in Q1 2018. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • Simplex Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 9,609 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $5.09K.
  • Simplex Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 36 quarters.
  • Simplex Trading's SANGAMO THERAPEUTICS INC position peaked at $957K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.